(HealthDay)—The British Cardiovascular Intervention Society myocardial jeopardy score (BCIS-JS) predicts mortality after percutaneous coronary intervention (PCI), according to research published in the Jan. 15 issue of ...
Jan 18, 2013
0
0
Social media may be an effective tool to help children overcome obesity, according to a new American Heart Association scientific statement.
Dec 3, 2012
0
0
The 38th Argentine Congress of Cardiology takes place 5 to 7 October 2012 in Buenos Aires, Argentina. The event is organised by the Argentine Society of Cardiology, which is an affiliated member of the European Society of ...
Oct 4, 2012
0
0
The overall rate of death in patients hospitalized with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack) decreased from 1995 to 2010 in France, with possible ...
Aug 27, 2012
0
0
(HealthDay) -- For patients presenting with ST-segment elevation myocardial infarction (STEMI), the decision for no reperfusion is usually multifactorial, with the most common factor being advanced age, according to a study ...
Aug 2, 2012
0
0
(HealthDay) -- Drug-eluting stents (DESs) do not seem to offer advantages over bare-metal stents (BMSs) for patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI) with stent implantation, ...
Jun 22, 2012
0
0
(HealthDay) -- For younger adults with premature coronary artery disease (CAD), percutaneous coronary intervention (PCI) is associated with excellent short- and long-term outcomes, according to a study published in the June ...
Jun 6, 2012
0
0
Life saving primary percutaneous coronary intervention (PPCI) treatment is increasing in countries participating in the Stent for Life Initiative.
May 16, 2012
0
0
(HealthDay) -- Elevated uric acid levels are predictive of one-year mortality in patients with acute coronary syndrome, according to a study published in the May 1 issue of The American Journal of Cardiology.
Apr 20, 2012
0
0
(HealthDay) -- Meta-analysis of randomized clinical trials (RCTs) suggests that drug-eluting stents (DESs) significantly reduce repeat revascularizations, with no increase in stent thrombosis (ST), mortality, or recurrent ...
Apr 4, 2012
0
0
